‹
Last 943.55 INR
Change Today +10.65 / 1.14%
Volume 10.8K
EMER On Other Exchanges
Symbol
Exchange
Natl India
As of 11:08 PM 01/27/15 All times are local (Market data is delayed by at least 15 minutes).

merck ltd (EMER) Snapshot

Open
933.30
Previous Close
932.90
Day High
951.25
Day Low
933.05
52 Week High
01/27/15 - 952.00
52 Week Low
02/3/14 - 535.00
Market Cap
15.7B
Average Volume 10 Days
71.8K
EPS TTM
33.70
Shares Outstanding
16.6M
EX-Date
03/10/14
P/E TM
28.0x
Dividend
8.50
Dividend Yield
0.90%
Current Stock Chart for MERCK LTD (EMER)

Related News

No related news articles were found.

merck ltd (EMER) Related Businessweek News

No Related Businessweek News Found

merck ltd (EMER) Details

Merck Limited manufactures and markets pharmaceuticals, bulk drugs, fine chemicals, and pigments primarily in India. The company operates in two segments, Pharmaceuticals and Chemicals. The Pharmaceuticals segment offers multi-vitamin products, such as Evion, Neurobion, and Polybion; Concor for cardio-vascular care; Carbophage for metabolic disorders; Livogen for haematinics treatment; and immuno-stimulator products comprising Immubron and Pedimune. This segment also provides consumer health care products, such as cough and cold, health protection, and women and children health products under the Nasivion, SevenSeas Original, Maxepa, Electrobion, and Evion Cream. The Chemicals segment primarily provides active pharmaceutical ingredients, excipients, and bio-pharmaceuticals for pharma and biopharma industries; pigments for the automotive, cosmetics, plastics, printing, and security industries; and various actives for the cosmetics industry, as well as functional and pearl luster effect pigments. Merck Limited also exports its products to Asian and African countries, such as Sri Lanka, Nepal, Lebanon, Kenya, Libya, and others. The company, formerly known as E. Merck Limited, was founded in 1967 and is based in Mumbai, India. Merck Limited is a subsidiary of Merck KGaA.

1,496 Employees
Last Reported Date: 02/24/14
Founded in 1967

merck ltd (EMER) Top Compensated Officers

Managing Director, Additional Director and Me...
Total Annual Compensation: 17.9M
Chief Financial Officer, Director of Finance,...
Total Annual Compensation: 6.6M
Compensation as of Fiscal Year 2013.

merck ltd (EMER) Key Developments

Merck Ltd. Announces Change in Directorate

Merck Ltd. announced that Mr. E. A. Kshirsagar, an Independent Director, has resigned from the Board of the company. Mr. Kshirsagar has resigned from the Board to create a vacancy for induction of a woman director on the Board of the company in compliance with the provisions of the Companies Act, 2013 since Merck follows the principles of keeping its board structure lean. Further, as part of Board restructuring, Mr. Pramod Pimplikar, an executive director, has resigned from the office of Director and Whole Time Director of the company.

Merck Ltd. Announces Executive Changes

Merck Ltd. has reported that Dr. Claus-Dieter Boedecker, Managing Director of the Company, has submitted a letter to the Board resigning from the office of Director and Managing Director of the Company due to his desire to relocate himself to his home country i.e. Germany. He has requested the Board to relieve him from his responsibilities by the close of business on January 31, 2015. At the request of Merck KGaA received pursuant to Articles of Association of the Company, the Nomination and Remuneration Committee at its meeting held on December 18, 2014 has recommended to the Board the appointment Mr. Anand Nambiar as the new Managing Director of the Company subject to the completion of various formalities, compliances, etc. as may be required in this regard.

Merck Ltd. Announces Executive Changes, Effective January 31, 2015

Merck Ltd. has announced that Dr. Claus-Dieter Boedecker, managing director of the company announced resigning from the office of director and managing director of the company due to his desire to relocate himself to his home country. He has requested the board to relieve him from his responsibilities by the close of business on January 31, 2015. At the request of Merck KGaA received pursuant to articles of association of the company, the Nomination and Remuneration Committee at its meeting held on December 18, 2014 has recommended to the board the appointment Mr. Anand Nambiar as the new Managing Director of the Company subject to the completion of various formalities, compliances, etc. as may be required in this regard.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EMER:IN 945.00 INR +12.10

EMER Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Gilead Sciences Inc $105.03 USD -2.08
Koninklijke DSM NV €46.15 EUR -0.065
Lonza Group AG SFr.104.10 CHF +2.00
Sigma-Aldrich Corp $137.42 USD -0.07
Thermo Fisher Scientific Inc $124.88 USD -0.76
View Industry Companies
 

Industry Analysis

EMER

Industry Average

Valuation EMER Industry Range
Price/Earnings 30.2x
Price/Sales 1.8x
Price/Book 2.8x
Price/Cash Flow 24.5x
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK LTD, please visit www.merck.co.in. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.

‹